Michael P. Lunn
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Journal: Journal of the peripheral nervous system : JPNS
Published: November 05, 2024
Mycophenolate Facilitates Improvement in Outcome Measures in Treatment Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Journal: Muscle & nerve
Published: October 17, 2024
Novel therapies in CIDP.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 10, 2024
Peripherin is a biomarker of axonal damage in peripheral nervous system disease.
Journal: Brain : a journal of neurology
Published: March 27, 2023
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision.
Journal: European journal of neurology
Published: May 16, 2021
Pain intensity and distribution in chronic inflammatory demyelinating polyneuropathy.
Journal: Muscle & nerve
Published: July 19, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026